Two promising startups win CHF 20’000 each at the second stage of Venture Kick
19.12.2016
Two great projects and their teams won the second stage of Venture Kick in December 2016: QuantActions from the University of Zurich and Epthera from ETH Zurich. They will soon pitch in front of the Venture Kick jury again at the big final, where they might win another CHF 100’000.
 The team of QuantActions
|
 |
 Franz-Josef Obermair from Epthera
|
|
QuantActions - From taps to insights (software): QuanAction provides the only secure, privacy-aware platform for analysis of tapping patterns on mobile devices. Its patented technology enables deep analysis of user activity for applications in multiple industries including healthcare, employee compliance, mobile app development and advertising. QuantActions technology is being used now in clinical studies. quantactions.com
Ephtera - Personalized cancer vaccines (Biotech): Personalized therapeutic cancer vaccines based on novel targets discovered using our proprietary MCR screening platform. This technology allows fast and effective identification of cancer specific peptides and provides a strong basis for efficient therapeutic vaccine development.